Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Stat Health is a medical technology company that has developed the world's first 24/7 in-ear wearable designed to monitor blood flow to the head. The device is specifically engineered to assist patients suffering from conditions like Postural Orthostatic Tachycardia Syndrome (POTS), syncope, and Long COVID by providing real-time data on physiological changes during orthostatic stress. By utilizing optical sensors in the ear, the device measures cerebral blood flow rather than just heart rate, offering deeper insights into the mechanisms of dizziness and fainting. The company aims to provide a non-invasive, long-term management solution for chronic conditions that affect blood pressure and cerebral perfusion. Founded by former Bose engineers, Stat Health focuses on bridging the diagnostic and management gap for millions of patients with invisible chronic illnesses.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Stat Health.